All stock lists
LENZ Therapeutics, Inc. (NASDAQ:LENZ)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
3.05+0.00 (+0.00%)
Market cap
$95.8M
Insider Score
Health Score
Analyst consensus
Listed since
Jun 25, 2021
Website
Insider Score
––Not scored
LENZ Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
LENZ analyst forecast
LENZ analyst consensus
Moderate Buy3 ratings
Buy 2 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
LENZ 12-month price target
No published price targets in the last 12 months.
LENZ ratings mix, last 12 months
Buy Hold Sell
Best analysts covering LENZ
- HC Wainwright & Co.17%success rate · -40.8% avg return · 6 calls
- Citigroup0%success rate · -74.9% avg return · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
LENZ analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-10-30 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-10-29 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-10-21 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2026-10-19 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2026-08-12 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-07-07 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-05-13 |
| — | Piper Sandler | Neutral | — | — | Downgraded | 2026-05-12 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-05-12 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-04-21 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-03-26 |
| — | B of A Securities | Buy | — | — | Reiterated | 2026-03-25 |
| — | Raymond James | Outperform | — | — | Reiterated | 2025-10-20 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-10-10 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-08-01 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-08-01 |
| — | Raymond James | Outperform | — | — | Reiterated | 2025-07-31 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-07-31 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-07-28 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-05-08 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-04-16 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-04-14 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-03-20 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-07 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-08-15 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-08-15 |
LENZ earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-24 | -0.91 | -1.16 | $3.1M | $1.6M |
| 2026-05-11 | -1.10 | -1.32 | $1.8M | $1.9M |
| 2026-08-11 | -1.05 | -1.02 | $2.4M | $5.5M |
| 2026-10-29 | -0.89 | -0.99 | $4.2M | $3.4M |
| 2027-03-23Upcoming | -0.83 | — | $4.2M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.